{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:51:39Z","timestamp":1790358699691,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ando.2020.03.010","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:45:07Z","timestamp":1584492307000},"page":"206-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Cardiovascular complications of acromegaly"],"prefix":"10.1016","volume":"82","author":[{"given":"Peter","family":"Kamenick\u00fd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Maione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Chanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ando.2020.03.010_bib0205","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1210\/er.2018-00115","article-title":"Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update","volume":"40","author":"Gadelha","year":"2019","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.ando.2020.03.010_bib0210","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/er.2009-0033","article-title":"Mortality in patients with pituitary disease","volume":"31","author":"Sherlock","year":"2010","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.ando.2020.03.010_bib0215","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41572-019-0129-5","article-title":"Acromegaly","volume":"5","author":"Colao","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ando.2020.03.010_bib0220","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/B978-0-444-59602-4.00014-9","article-title":"Acromegaly","volume":"124","author":"Chanson","year":"2014","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"10.1016\/j.ando.2020.03.010_bib0225","doi-asserted-by":"crossref","first-page":"101264","DOI":"10.1016\/j.beem.2019.02.001","article-title":"National acromegaly registries","volume":"33","author":"Maione","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ando.2020.03.010_bib0230","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/HJH.0000000000000962","article-title":"Role of ambulatory blood pressure monitoring in patients with acromegaly","volume":"34","author":"Costenaro","year":"2016","journal-title":"J Hypertens"},{"issue":"7","key":"10.1016\/j.ando.2020.03.010_bib0235","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1172\/JCI102977","article-title":"Body water and sodium in patients with acromegaly","volume":"33","author":"Ikkos","year":"1954","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.ando.2020.03.010_bib0240","first-page":"465","article-title":"Reversible plasma and red blood cells volumes increases in acromegaly","volume":"85","author":"Strauch","year":"1977","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"7","key":"10.1016\/j.ando.2020.03.010_bib0245","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1210\/en.2008-0143","article-title":"Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegaly","volume":"149","author":"Kamenicky","year":"2008","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.ando.2020.03.010_bib0250","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1210\/jc.2011-0078","article-title":"Body fluid expansion in acromegaly is related to enhanced epithelial sodium channel (ENaC) activity","volume":"96","author":"Kamenicky","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ando.2020.03.010_bib0255","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/er.2013-1071","article-title":"Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications","volume":"35","author":"Kamenick\u00fd","year":"2014","journal-title":"Endocr Rev"},{"issue":"10","key":"10.1016\/j.ando.2020.03.010_bib0260","first-page":"1086","article-title":"American Society of Echocardiography. American Society of Echocardiography recommendations for use of echocardiography in clinical trials","volume":"17","author":"Gottdiener","year":"2004","journal-title":"J Am Soc Echocardiogr"},{"issue":"1","key":"10.1016\/j.ando.2020.03.010_bib0265","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9149(02)02381-0","article-title":"Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy","volume":"90","author":"Grothues","year":"2002","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.ando.2020.03.010_bib0270","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0735-1097(03)00189-X","article-title":"Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance","volume":"41","author":"Moon","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ando.2020.03.010_bib0275","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1210\/jc.2015-2675","article-title":"Low Frequency of Cardiomyopathy Using Cardiac Magnetic Resonance Imaging in an Acromegaly Contemporary Cohort","volume":"100","author":"Dos Santos Silva","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ando.2020.03.010_bib0280","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.2214\/AJR.07.2031","article-title":"Rapidly reversible myocardial edema in patients with acromegaly: assessment with ultrafast T2 mapping in a single-breath-hold MRI sequence","volume":"190","author":"Gouya","year":"2008","journal-title":"AJR Am Roentgenol"},{"issue":"5","key":"10.1016\/j.ando.2020.03.010_bib0285","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1536\/ihj.53.299","article-title":"Evaluation of left ventricular diastolic function according to new criteria and determinants in acromegaly","volume":"53","author":"Akdeniz","year":"2012","journal-title":"Int Heart J"},{"issue":"2","key":"10.1016\/j.ando.2020.03.010_bib0290","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1172\/JCI114737","article-title":"Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle","volume":"86","author":"Timsit","year":"1990","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.ando.2020.03.010_bib0295","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/jcu.22529","article-title":"Left ventricular twist is impaired in acromegaly: Insights from the three-dimensional speckle tracking echocardiographic MAGYAR-Path Study","volume":"46","author":"Korm\u00e1nyos","year":"2018","journal-title":"J Clin Ultrasound"},{"issue":"7","key":"10.1016\/j.ando.2020.03.010_bib0300","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/echo.13860","article-title":"Three-dimensional speckle tracking echocardiography-derived left atrial deformation analysis in acromegaly (Results from the MAGYAR-Path Study)","volume":"35","author":"Korm\u00e1nyos","year":"2018","journal-title":"Echocardiography"},{"issue":"11","key":"10.1016\/j.ando.2020.03.010_bib0305","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1210\/jc.2004-0821","article-title":"Long-term outcome of patients with acromegaly and congestive heart failure","volume":"89","author":"Bihan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ando.2020.03.010_bib0310","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/EJE-16-1064","article-title":"French Acromegaly Registry Group. Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry","volume":"176","author":"Maione","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.ando.2020.03.010_bib0315","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1210\/jc.2006-2547","article-title":"Impact of somatostatin analogs on the heart in acromegaly: a metaanalysis","volume":"92","author":"Maison","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ando.2020.03.010_bib0320","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1530\/EJE-15-0500","article-title":"Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study","volume":"173","author":"Kuhn","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.ando.2020.03.010_bib0325","doi-asserted-by":"crossref","first-page":"921","DOI":"10.7326\/0003-4819-113-12-921","article-title":"Cardiovascular effects of the somatostatin analog octreotide in acromegaly","volume":"113","author":"Chanson","year":"1990","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.ando.2020.03.010_bib0330","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1210\/jc.2009-2570","article-title":"Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control","volume":"95","author":"Berg C1","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ando.2020.03.010_bib0335","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1365-2265.2001.01281.x","article-title":"Characterization of premature atherosclerosis of carotid arteries in acromegalic patients","volume":"54","author":"Otsuki","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.ando.2020.03.010_bib0340","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1210\/jc.2010-2225","article-title":"Changes in arterial stiffness but not carotid intimal thickness in acromegaly","volume":"96","author":"Paisley","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ando.2020.03.010_bib0345","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1530\/EJE-09-0945","article-title":"Acromegaly per se does not increase the risk for coronary artery disease","volume":"162","author":"Akutsu","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.ando.2020.03.010_bib0350","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1210\/jc.2007-1213","article-title":"Risk factors for development of coronary heart disease in patients with acromegaly: a five-year prospective study","volume":"92","author":"Bogazzi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ando.2020.03.010_bib0355","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1530\/EJE-16-0562","article-title":"Disease activity and lifestyle influence comorbidities and cardiovascular events in patients with acromegaly","volume":"175","author":"Sardella","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.ando.2020.03.010_bib0360","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s11102-017-0827-5","article-title":"Incidence of myocardial infarction and stroke in acromegaly patients: results from the German Acromegaly Registry","volume":"20","author":"Sch\u00f6fl","year":"2017","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.ando.2020.03.010_bib0365","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1530\/EJE-12-0753","article-title":"Active acromegaly is associated with decreased hs-CRP and NT-proBNP serum levels: insights from the Belgian registry of acromegaly","volume":"168","author":"Verhelst","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.ando.2020.03.010_bib0370","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/oxfordjournals.eurheartj.a060047","article-title":"Arrhythmia profile in acromegaly","volume":"13","author":"Kahaly","year":"1992","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ando.2020.03.010_bib0375","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1210\/jc.2013-4288","article-title":"Impact of successful treatment of acromegaly on overnight heart rate variability and sleep apnea","volume":"99","author":"Chemla","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ando.2020.03.010_bib0380","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s11102-014-0605-6","article-title":"Heart rate variability is reduced in acromegaly patients and improved by treatment with somatostatin analogues","volume":"18","author":"Comunello","year":"2015","journal-title":"Pituitary"},{"issue":"6","key":"10.1016\/j.ando.2020.03.010_bib0385","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s11102-016-0749-7","article-title":"Low frequency of cardniac arrhythmias and lack of structural heart disease in medically-na\u00efve acromegaly patients: a prospective study at baseline and after 1 year of somatostatin analogs treatment","volume":"19","author":"Warszawski","year":"2016","journal-title":"Pituitary"},{"issue":"7","key":"10.1016\/j.ando.2020.03.010_bib0390","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1210\/jc.2002-021099","article-title":"High prevalence of cardiac valve disease in acromegaly: an observational, analytical, case-control study","volume":"88","author":"Colao","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ando.2020.03.010_bib0395","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1210\/jc.2003-030849","article-title":"Increased prevalence of regurgitant valvular heart disease in acromegaly","volume":"89","author":"Pereira","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ando.2020.03.010_bib0400","doi-asserted-by":"crossref","first-page":"E1714","DOI":"10.1210\/jc.2012-1833","article-title":"No evidence of a detrimental effect of cabergoline therapy on cardiac valves in patients with acromegaly","volume":"97","author":"Maione","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426620300457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426620300457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:53:09Z","timestamp":1757717589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426620300457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":40,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0003426620300457"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2020.03.010","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular complications of acromegaly","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2020.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}